×
Back to Agenda
Part 3: Financing Biotech: Why Financial Thinking Matters as Much as the Science for Successful Outcomes and Exits
Session Chair(s)
Sahirzeeshan Ali
Founder and General Partner
Modi Ventures, United States
Andrew Lo, PHD, MA, MBA, PMP
Charles E. and Susan T. Harris Professor of Finance, Sloan School of Management
Massachusetts Institute of Technology (MIT), United States
This session introduces the foundational financial models used in the biotech and healthcare industries, highlighting the unique factors that influence valuation and investment decisions. Participants will gain insight into common exit strategies—including IPOs, mergers and acquisitions, and licensing—and learn how these pathways shape financial planning and strategic growth.
Have an account?